OFIX logo

Orthofix Medical Inc. (OFIX)

$6.67

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on OFIX

Market cap

$271867873

EPS

-1.11

P/E ratio

--

Price to sales

0.45

Dividend yield

--

Beta

0.661044

Price on OFIX

Previous close

$6.80

Today's open

$6.71

Day's range

$6.62 - $6.91

52 week range

$6.52 - $16.42

Profile about OFIX

CEO

Massimo Calafiore

Employees

1605

Headquarters

Lewisville, TX

Exchange

Nasdaq Global Select

Shares outstanding

40759801

Issue type

Common Stock

OFIX industries and sectors

Healthcare

Medical Equipment & Supplies

News on OFIX

Orthofix (OFIX) Upgraded to Buy: What Does It Mean for the Stock?

Orthofix (OFIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news source

Zacks Investment Research • 4 hours ago

news preview

Orthofix Medical Q3 Earnings Call Highlights

Orthofix Medical NASDAQ: OFIX lowered its 2026 outlook after third-quarter results fell short of management's expectations, as softer U.S. spine procedure volumes and supplier delays constrained its ability to support demand.

news source

MarketBeat • Nov 9, 2026

news preview

Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript

Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 9, 2026

news preview

Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026, and revised its full-year 2026 net sales and non-GAAP adjusted EBITDA guidance. Unless otherwise noted, pro forma results exclude the impact of the discontinued M6™ product lines. Third Quarter 2026 Highlights Total reported net sales of $207.9 million, representing an increase of 1% on a reported b.

news source

Business Wire • Nov 9, 2026

news preview

Orthofix (OFIX) Surpasses Q3 Earnings Estimates

Orthofix (OFIX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.2 per share a year ago.

news source

Zacks Investment Research • Nov 9, 2026

news preview

Orthofix (OFIX) Surges 11.0%: Is This an Indication of Further Gains?

Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Orthofix to Report Third Quarter 2026 Financial Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing 833-461-5787 in the U.S., and 585-542-9983 in all other locations, and referencing th.

news source

Business Wire • Oct 23, 2026

news preview

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)

NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Orthofix Medical Inc. (NASDAQ: OFIX) concerning possible breaches of fiduciary duties. If you are a current shareholder of OFIX, you can request additional information here: https://zlk.com/cases/orthofix-medical-inc-class-action-lawsuit-ofix-2 or contact Joseph E.

news source

PRNewsWire • Oct 21, 2026

news preview

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

news source

PRNewsWire • Oct 13, 2026

news preview

Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook

Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected European inventory order, partly offset by a steeper-than-anticipated decline among smaller U.S. spine distributors.

news source

MarketBeat • Aug 16, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Orthofix Medical Inc.

Open an M1 investment account to buy and sell Orthofix Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in OFIX on M1